Skip to main content

Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder.

Tools

Baldwin, D.S., Buis, C. and Mayers, A.G., 2002. Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder. Expert Review of Neurotherapeutics, 2 (5), 717-724.

This is the latest version of this eprint.

Full text available as:

[img]
Preview
 PDF
SSRIs_in_Anxiety.pdf
135kB

Copyright to original material in this document is with the original owner(s). Access to this content through BURO is granted on condition that you use it only for research, scholarly or other non-commercial purposes. If you wish to use it for any other purposes, you must contact BU via BURO@bournemouth.ac.uk.

Any third party copyright material in this document remains the property of its respective owner(s). BU grants no licence for further use of that third party material.

DOI: 10.1586/14737175.2.5.717

Abstract

Selective serotonin reuptake inhibitors have proven efficacy in the treatment of panic disorder, obsessive–compulsive disorder, post-traumatic stress disorder and social anxiety disorder. Accumulating data shows that selective serotonin reuptake inhibitor treatment can also be efficacious in patients with generalized anxiety disorder. This review summarizes the findings of randomized controlled trials of selective serotonin reuptake inhibitor treatment for generalized anxiety disorder, examines the strengths and weaknesses of other therapeutic approaches and considers potential new treatments for patients with this chronic and disabling anxiety disorder.

Item Type:Article
ISSN:1473-7175
Group:Faculty of Science & Technology
ID Code:17267
Deposited By: Dr Andrew Mayers
Deposited On:31 Jan 2011 16:03
Last Modified:14 Mar 2022 13:37

Available Versions of this Item

Downloads

Downloads per month over past year

More statistics for this item...
Repository Staff Only -